Mersana Therapeutics Inc (MRSN)
2.725
+0.14
(+5.62%)
USD |
NASDAQ |
May 17, 16:00
2.725
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Free Cash Flow: -173.92M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -173.92M |
| December 31, 2023 | -171.05M |
| September 30, 2023 | -190.72M |
| June 30, 2023 | -89.99M |
| March 31, 2023 | -73.19M |
| December 31, 2022 | -51.56M |
| September 30, 2022 | -42.10M |
| June 30, 2022 | -132.42M |
| March 31, 2022 | -121.78M |
| December 31, 2021 | -140.64M |
| September 30, 2021 | -115.59M |
| June 30, 2021 | -99.84M |
| March 31, 2021 | -80.99M |
| December 31, 2020 | -75.17M |
| September 30, 2020 | -70.24M |
| Date | Value |
|---|---|
| June 30, 2020 | -66.16M |
| March 31, 2020 | -64.60M |
| December 31, 2019 | -68.35M |
| September 30, 2019 | -71.95M |
| June 30, 2019 | -66.39M |
| March 31, 2019 | -63.99M |
| December 31, 2018 | -56.59M |
| September 30, 2018 | -52.11M |
| June 30, 2018 | -52.55M |
| March 31, 2018 | -50.10M |
| December 31, 2017 | -43.82M |
| September 30, 2017 | -18.69M |
| June 30, 2017 | -12.33M |
| March 31, 2017 | -12.55M |
| December 31, 2016 | 30.50M |
Free Cash Flow Range, Past 5 Years
-190.72M
Minimum
Sep 2023
-42.10M
Maximum
Sep 2022
-98.33M
Average
-78.08M
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics Inc | -88.03M |
| Geron Corp | -184.70M |
| Insmed Inc | -588.55M |
| Altimmune Inc | -72.76M |
| InfuSystems Holdings Inc | 3.244M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -32.66M |
| Cash from Investing (Quarterly) | -72.55M |
| Cash from Financing (Quarterly) | 5.829M |
| Free Cash Flow Per Share (Quarterly) | -0.27 |
| Free Cash Flow to Equity (Quarterly) | -32.86M |
| Free Cash Flow Yield | -53.29% |